Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status. Leidinger, P., Hart, M., Backes, C., Rheinheimer, S., Keck, B., Wullich, B., Keller, A., & Meese, E. Tumour Biol., Jan, 2016.
bibtex   
@Article{pmid26831660,
   Author="Leidinger, P.  and Hart, M.  and Backes, C.  and Rheinheimer, S.  and Keck, B.  and Wullich, B.  and Keller, A.  and Meese, E. ",
   Title="{{D}ifferential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: mi{R}{N}{A} as source for biomarkers independent of {P}{S}{A} level, {G}leason score, or {T}{N}{M} status}",
   Journal="Tumour Biol.",
   Year="2016",
   Pages=" ",
   Month="Jan"
}

Downloads: 0